Duvic M - Search Results

1

Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action.

Zhang C, Hazarika P, Ni X, Weidner DA, Duvic M. Zhang C, et al. Among authors: duvic m. Clin Cancer Res. 2002 May;8(5):1234-40. Clin Cancer Res. 2002. PMID: 12006543

2

Cutaneous T-cell lymphoma in association with silicone breast implants.

Duvic M, Moore D, Menter A, Vonderheid EC. Duvic M, et al. J Am Acad Dermatol. 1995 Jun;32(6):939-42. doi: 10.1016/0190-9622(95)91328-9. J Am Acad Dermatol. 1995. PMID: 7751462

3

Combined modality therapy for cutaneous T-cell lymphoma.

Duvic M, Lemak NA, Redman JR, Eifel PJ, Tucker SL, Cabanillas FF, Kurzrock R. Duvic M, et al. J Am Acad Dermatol. 1996 Jun;34(6):1022-9. doi: 10.1016/s0190-9622(96)90282-0. J Am Acad Dermatol. 1996. PMID: 8647968

4

HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma.

Jackow CM, McHam JB, Friss A, Alvear J, Reveille JR, Duvic M. Jackow CM, et al. Among authors: duvic m. J Invest Dermatol. 1996 Sep;107(3):373-6. doi: 10.1111/1523-1747.ep12363352. J Invest Dermatol. 1996. PMID: 8751973 Free article.

5

Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts.

Konstantinova NV, Duong DM, Remenyik E, Hazarika P, Chuang A, Duvic M. Konstantinova NV, et al. Among authors: duvic m. J Invest Dermatol. 1996 Oct;107(4):615-21. doi: 10.1111/1523-1747.ep12584215. J Invest Dermatol. 1996. PMID: 8823370 Free article.

6

Photopheresis therapy for cutaneous T-cell lymphoma.

Duvic M, Hester JP, Lemak NA. Duvic M, et al. J Am Acad Dermatol. 1996 Oct;35(4):573-9. doi: 10.1016/s0190-9622(96)90683-0. J Am Acad Dermatol. 1996. PMID: 8859287

7

Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas.

Sarris AH, Daliani D, Ulmer R, Crow M, Broxmeyer HE, Pugh W, Reiss M, Cabanillas F, Deisseroth AB, Duvic M. Sarris AH, et al. Among authors: duvic m. Leuk Lymphoma. 1996 Dec;24(1-2):103-10. doi: 10.3109/10428199609045718. Leuk Lymphoma. 1996. PMID: 9049966 Clinical Trial.

8

DAB389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma.

Duvic M, Cather J, Maize J, Frankel AE. Duvic M, et al. Am J Hematol. 1998 May;58(1):87-90. doi: 10.1002/(sici)1096-8652(199805)58:1<87::aid-ajh18>3.0.co;2-2. Am J Hematol. 1998. PMID: 9590158 Free article.

9

Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10.

Daliani D, Ulmer RA, Jackow C, Pugh W, Gansbacher B, Cabanillas F, Duvic M, Sarris AH. Daliani D, et al. Among authors: duvic m. Leuk Lymphoma. 1998 Apr;29(3-4):315-28. doi: 10.3109/10428199809068568. Leuk Lymphoma. 1998. PMID: 9684929 Review.

10

Antinuclear antibody seropositivity in patients with cutaneous T-cell lymphoma.

Peterson SR, Talpur R, Duvic M. Peterson SR, et al. Among authors: duvic m. J Am Acad Dermatol. 1998 Sep;39(3):434-8. doi: 10.1016/s0190-9622(98)70320-2. J Am Acad Dermatol. 1998. PMID: 9738778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters